Skip to content

Psychometric Properties of the Five Facets Mindfulness Questionnaire in Moderate-to-Severe, Persistent Depression

T. Sweeney, Richard Morriss, Elena Nixon, B. Guo, P. Callaghan

Mindfulness January 18, 2021 DOI: 10.1007/s12671-020-01573-6 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Psychometric validation study using secondary data from a randomized controlled trial Peer reviewed
Sample size 187
Population Individuals with moderate-to-severe persistent depression
Measures Five Facets Mindfulness Questionnaire (FFMQ), measures of depression, self-compassion, rumination, experiential avoidance
Topics Depression Meditation
Registration NCT01047124
Key findings Internal consistency of the FFMQ was supported, and correlated and hierarchical models fit acceptably, with the correlated model slightly favored. Contrary to predictions, Observe loaded strongly on an overarching mindfulness factor while Nonjudge loaded marginally and was not significantly correlated with depression; post hoc analyses were inconsistent with the confirmatory results. The authors suggest these contradictory findings about "Nonjudge" may challenge the FFMQ's validity in this sample and warrant further investigation.

Abstract

Mindfulness has been increasingly incorporated into modern psychotherapies and healthcare services. The importance of psychometrically quantifying the construct of mindfulness has become paramount. One of the most reliable and valid instruments for the assessment of different aspects of dispositional mindfulness is the Five Facets Mindfulness Questionnaire (FFMQ). However, the psychometric properties of the FFMQ are yet to be tested in individuals with high levels of persistent depression. This study therefore investigated the psychometric properties of the FFMQ in a clinical sample with moderate-to-severe, persistent depression. The data of 187 participants recruited from a funded randomised controlled trial were utilised. Internal consistency was assessed and construct validity was examined with confirmatory factor analyses (CFA) and by statistically correlating the FFMQ to measures of depression, self-compassion, rumination and experiential avoidance. Findings supported the internal consistency of the FFMQ. CFA fit indices indicated that all correlated and hierarchical models fitted the data acceptably, with results slightly favouring the correlated model. Contrary to predictions however, individual facet loadings showed that the facet Observe loaded strongly onto an overarching factor of mindfulness, whilst Nonjudge loaded marginally. Nonjudge further showed a non-significant correlation with depression. However, exploratory post hoc analysis presented findings inconsistent with CFA. In a sample of severely depressed individuals, psychometric investigation of the validity of the FFMQ highlighted contradictory findings relating to “Nonjudge”. Whilst such findings potentially challenge the validity of the FFMQ for use in its current structure in this sample, further investigation with a larger population is warranted. ClinicalTrials.gov (NCT01047124) and the ISRCTN registry (ISRCTN10963342)

Comparable studies

Other randomized controlled trials on depression, most cited first.

Study Year Design Participants
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Subjects with DSM-IV major depression (treatment resistant) 2006 Randomized, placebo-controlled, double-blind crossover study n = 18
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics